---
title: "Fulai New Material and Tongzhi Technology Strategic Cooperation to Jointly Promote the Construction of Embodied Intelligence Ecosystem"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262915428.md"
description: "On October 27th, Fulai New Material officially signed a strategic cooperation agreement with Tongzhi Artificial Intelligence Technology Co., Ltd. Both parties will carry out in-depth cooperation based on their core capabilities in flexible sensing and artificial intelligence, jointly promoting the construction of an integrated embodied intelligence ecosystem of \"materials - perception - algorithms - terminals.\""
datetime: "2025-10-27T13:29:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262915428.md)
  - [en](https://longbridge.com/en/news/262915428.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262915428.md)
---

# Fulai New Material and Tongzhi Technology Strategic Cooperation to Jointly Promote the Construction of Embodied Intelligence Ecosystem

On October 27th, Fulai New Material officially signed a strategic cooperation agreement with Tongzhi Artificial Intelligence Technology Co., Ltd. Both parties will carry out in-depth cooperation based on their core capabilities in flexible sensing and artificial intelligence, jointly promoting the construction of an integrated embodied intelligence ecosystem of "materials-sensing-algorithms-terminals."

### Related Stocks

- [605488.CN](https://longbridge.com/en/quote/605488.CN.md)

## Related News & Research

- [CMOC Group (CMCLF): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/286625840.md)
- [Finsbury Growth & Income Trust Director Reinvests Dividends into Company Shares](https://longbridge.com/en/news/286940848.md)
- [HSA warns public against consuming herbal remedy containing potent steroid](https://longbridge.com/en/news/287022845.md)
- [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md)
- [4basebio signs clinical supply agreement for Phase II immunotherapy trial opDNA material](https://longbridge.com/en/news/287052696.md)